Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 51,189 DMAC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 51,189 | n/a |
| Jun 3, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Grant/Award | 30,000 | n/a |
| Mar 13, 2026 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase | 10,000 | $10.3K |
| Jan 6, 2026 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 10,095 | $85.0K |
| Nov 25, 2025 | DiaMedica Therapeutics Inc. (DMAC) | Exercise/Conversion | 12,000 | $26.4K |
| Jun 3, 2025 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 40,739 | n/a |
| Jan 3, 2025 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 15,917 | $85.0K |
| Jun 3, 2024 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 28,472 | n/a |
| Jan 2, 2024 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 21,428 | $60.0K |
| Jun 2, 2023 | DiaMedica Therapeutics Inc. (DMAC) | Grant/Award | 16,968 | n/a |